Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity — Stella

Recruiting

Back to Primary Hyperparathyroidism trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

ProMedica Toledo Hospital, Toledo, Ohio

Key details

Phase

Post-approval study

Sponsor

Joseph Sferra

Collaborators

University of Toledo Health Science Campus

Enrollment target

~37 participants

Started

May 2019

Primary completion

June 2026

Age range

18 Years and older

Last updated September 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov